| Eton Pharmaceuticals, Inc. | 2.44M | US$126M | 14.2% |
| Disc Medicine, Inc. | 1.09M | US$71.7M | 8.1% |
| Harrow, Inc. | 2.1M | US$64.8M | 7.3% |
| Liquidia Corporation | 2.11M | US$63.8M | 7.2% |
| MeiraGTx Holdings plc | 3.6M | US$39.6M | 4.5% |
| TG Therapeutics, Inc. | 557K | US$31.1M | 3.5% |
| Alpha Cognition Inc. | 3.3M | US$29.7M | 3.3% |
| Immix Biopharma, Inc. | 2.83M | US$29.4M | 3.3% |
| Crescent Biopharma, Inc. | 1.65M | US$24M | 2.7% |
| Verastem, Inc. | 2.75M | US$22.2M | 2.5% |
| Revolution Medicines, Inc. | 100K | US$20.5M | 2.3% |
| Replimune Group, Inc. | 1.38M | US$18.3M | 2.1% |
| Stoke Therapeutics, Inc. | 692K | US$18M | 2.0% |
| Summit Therapeutics Inc. | 1.05M | US$17.8M | 2.0% |
| Rezolute, Inc. | 4.09M | US$16.9M | 1.9% |
| Biohaven Ltd. | 1.19M | US$15.9M | 1.8% |
| Protagonist Therapeutics, Inc. | 100K | US$14.1M | 1.6% |
| Monte Rosa Therapeutics, Inc. | 1.03M | US$12.3M | 1.4% |
| Rhythm Pharmaceuticals, Inc. | 123K | US$11.7M | 1.3% |
| Q32 Bio Inc. | 1.12M | US$9.26M | 1.0% |
| Harmony Biosciences Holdings, Inc. | 230K | US$9.03M | 1.0% |
| Editas Medicine, Inc. | 3.49M | US$8.96M | 1.0% |
| Alumis Inc. | 1M | US$7.4M | 0.83% |
| Edgewise Therapeutics, Inc. | 175K | US$7.11M | 0.80% |
| Grace Therapeutics, Inc. | 2.8M | US$6.02M | 0.68% |
| Syndax Pharmaceuticals, Inc. | 315K | US$5.93M | 0.67% |
| Jasper Therapeutics, Inc. | 281K | US$4.89M | 0.55% |
| 4D Molecular Therapeutics, Inc. | 334K | US$4.79M | 0.54% |
| Inhibrx Biosciences, Inc. | 45,500 | US$4.55M | 0.51% |
| Cabaletta Bio, Inc. | 2.32M | US$4.46M | 0.50% |
| Trevi Therapeutics, Inc. | 310K | US$4.44M | 0.50% |
| Voyager Therapeutics, Inc. | 1.63M | US$4.37M | 0.49% |
| Zentalis Pharmaceuticals, Inc. | 1.41M | US$3.91M | 0.44% |
| Ocular Therapeutix, Inc. | 506K | US$3.88M | 0.44% |
| Relmada Therapeutics, Inc. | 1M | US$3.77M | 0.42% |
| Annexon, Inc. | 875K | US$3.7M | 0.42% |
| Opus Genetics, Inc. | 750K | US$3.63M | 0.41% |
| Codexis, Inc. | 2.59M | US$3.6M | 0.41% |
| BlossomHill Therapeutics, Inc. | 175K | US$3.26M | 0.37% |
| Lyell Immunopharma, Inc. | 291K | US$2.85M | 0.32% |
| Rocket Pharmaceuticals, Inc. | 1M | US$2.63M | 0.30% |
| Biodesix, Inc. | 87,000 | US$2.6M | 0.29% |
| BridgeBio Oncology Therapeutics, Inc. | 630K | US$2.58M | 0.29% |
| Jade Biosciences, Inc. | 140K | US$1.97M | 0.22% |
| Enanta Pharmaceuticals, Inc. | 125K | US$1.65M | 0.19% |
| Fortress Biotech, Inc. | 720K | US$1.54M | 0.17% |
| SANUWAVE Health, Inc. | 306K | US$1.44M | 0.16% |
| MBX Biosciences, Inc. | 20,000 | US$1.17M | 0.13% |
| Obsidian Therapeutics, Inc. | 75,755 | US$1.04M | 0.12% |
| Journey Medical Corporation | 125K | US$855K | 0.10% |
| Korro Bio, Inc. | 69,348 | US$687K | 0.08% |
| Sionna Therapeutics, Inc. | 70,000 | US$368K | 0.04% |
| Adagio Medical Holdings, Inc | 18,444 | US$2,822 | <0.01% |
| XOMA Royalty Corporation | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Atea Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| CG Oncology, Inc. | 0 | US$0 | 0.00% |
| First Tracks Biotherapeutics, Inc. | 0 | US$0 | 0.00% |
| Hemab Therapeutics Holdings, Inc. | 0 | US$0 | 0.00% |
| Intellia Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Palatin Technologies, Inc. | 0 | US$0 | 0.00% |
| Pasithea Therapeutics Corp. | 0 | US$0 | 0.00% |
| Phathom Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |